CY1118217T1 - Ανοργανα νανοσωματιδια υψηλης πυκνοτητας για καταστροφη κυτταρων in-vivo - Google Patents
Ανοργανα νανοσωματιδια υψηλης πυκνοτητας για καταστροφη κυτταρων in-vivoInfo
- Publication number
- CY1118217T1 CY1118217T1 CY20161101109T CY161101109T CY1118217T1 CY 1118217 T1 CY1118217 T1 CY 1118217T1 CY 20161101109 T CY20161101109 T CY 20161101109T CY 161101109 T CY161101109 T CY 161101109T CY 1118217 T1 CY1118217 T1 CY 1118217T1
- Authority
- CY
- Cyprus
- Prior art keywords
- particles
- vivo
- health
- relates
- inorganic nanoparticles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
Η παρούσα αίτηση σχετίζεται με νέα διεγέρσιμα σωματίδια τα οποία μπορεί να χρησιμοποιηθούν στον τομέα της υγείας. Πιο συγκεκριμένα σχετίζεται με σωματίδια τα οποία μπορεί να παράγουν ηλεκτρόνια και/ή υψηλής ενέργειας φωτόνιο όταν διεγερθούν με ιονίζουσες ακτινοβολίες όπως Ακτίνες Χ, Ακτίνες γάμμα, ραδιενεργό ισότοπο και/ή δέσμες ηλεκτρονίων, και με τις χρήσεις αυτών στην υγεία, ειδικότερα στην ανθρώπινη υγεία. Τα σωματίδια της εφεύρεσης αποτελούνται από ένα ανόργανο υλικό το οποίο περιλαμβάνει οξυγόνο, πιο συγκεκριμένα ένα οξείδιο, με το εν λόγω υλικό να έχει μία επαρκή πυκνότητα, και μπορεί να ενεργοποιηθούν in vitro, ex vivo, ή in vivo, με ελεγχόμενη εξωτερική διέγερση, για να διαταράξουν, να τροποποιήσουν ή να καταστρέψουν κύτταρα, ιστούς ή όργανα στόχους. Η εφεύρεση επίσης σχετίζεται με μεθόδους για την παραγωγή των εν λόγω σωματιδίων, και με φαρμακευτικές συνθέσεις ή συνθέσεις ιατρικών συσκευών οι οποίες τα περιέχουν.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08157686A EP2130553A1 (en) | 2008-06-05 | 2008-06-05 | Inorganic nanoparticles of high density to destroy cells in-vivo |
| US6020208P | 2008-06-10 | 2008-06-10 | |
| PCT/EP2009/056880 WO2009147214A2 (en) | 2008-06-05 | 2009-06-04 | Inorganic nanoparticles, preparation and uses thereof |
| EP09757595.5A EP2300054B1 (en) | 2008-06-05 | 2009-06-04 | Inorganic nanoparticles of high density to destroy cells in-vivo |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1118217T1 true CY1118217T1 (el) | 2017-06-28 |
Family
ID=39734334
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20161101109T CY1118217T1 (el) | 2008-06-05 | 2016-11-01 | Ανοργανα νανοσωματιδια υψηλης πυκνοτητας για καταστροφη κυτταρων in-vivo |
| CY181101377T CY1121078T1 (el) | 2008-06-05 | 2018-12-19 | Ανοργανα νανοσωματιδια υψηλης πυκνοτητας για καταστροφη κυτταρων in-vivo |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY181101377T CY1121078T1 (el) | 2008-06-05 | 2018-12-19 | Ανοργανα νανοσωματιδια υψηλης πυκνοτητας για καταστροφη κυτταρων in-vivo |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US8845507B2 (el) |
| EP (4) | EP2130553A1 (el) |
| JP (1) | JP5734181B2 (el) |
| KR (1) | KR101639281B1 (el) |
| CN (1) | CN102056628B (el) |
| AU (1) | AU2009254550B2 (el) |
| BR (1) | BRPI0913410B1 (el) |
| CA (1) | CA2727576C (el) |
| CY (2) | CY1118217T1 (el) |
| DK (2) | DK2300054T3 (el) |
| EA (1) | EA023012B1 (el) |
| ES (2) | ES2602048T3 (el) |
| HR (2) | HRP20161465T8 (el) |
| HU (2) | HUE030669T2 (el) |
| IL (1) | IL209625A (el) |
| LT (2) | LT2300054T (el) |
| MA (1) | MA32453B1 (el) |
| MX (1) | MX2010013322A (el) |
| NZ (1) | NZ589888A (el) |
| PL (2) | PL2300054T3 (el) |
| PT (2) | PT3150227T (el) |
| SG (1) | SG10201405288WA (el) |
| SI (2) | SI3150227T1 (el) |
| TR (1) | TR201819077T4 (el) |
| WO (1) | WO2009147214A2 (el) |
| ZA (1) | ZA201100082B (el) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070164238A1 (en) * | 2003-02-24 | 2007-07-19 | Pomper Mark E | Mobile radiation treatment vehicle and method |
| US8657354B2 (en) | 2006-05-19 | 2014-02-25 | Breya, Llc. | Mobile radiation therapy |
| US8459714B2 (en) | 2006-05-19 | 2013-06-11 | Breya, Llc. | Mobile radiation therapy |
| US9399075B2 (en) | 2008-12-29 | 2016-07-26 | General Electric Company | Nanoparticle contrast agents for diagnostic imaging |
| US8728440B2 (en) | 2012-08-23 | 2014-05-20 | General Electric Company | Nanoparticulate compositions for diagnostic imaging |
| US9585840B1 (en) | 2009-07-10 | 2017-03-07 | University Of Central Florida Research Foundation, Inc. | Redox active cerium oxide nanoparticles and associated methods |
| EP2275137A1 (en) * | 2009-07-10 | 2011-01-19 | Nanobiotix | Metallic nanoparticles, preparation and uses thereof |
| TWI572389B (zh) | 2009-11-10 | 2017-03-01 | 伊穆諾萊特公司 | 用於產生介質中之改變之儀器組及系統、用於產生光或固化之系統、輻射固化或可固化物品、微波或rf接受器及用於治療或診斷之系統 |
| WO2011133228A2 (en) | 2010-04-23 | 2011-10-27 | Pixelligent Technologies, Llc | Synthesis, capping and dispersion of nanocrystals |
| CN107416764A (zh) | 2010-10-27 | 2017-12-01 | 皮瑟莱根特科技有限责任公司 | 纳米晶体的合成、盖帽和分散 |
| US9359689B2 (en) | 2011-10-26 | 2016-06-07 | Pixelligent Technologies, Llc | Synthesis, capping and dispersion of nanocrystals |
| SG11201403096VA (en) | 2011-12-16 | 2014-07-30 | Nanobiotix | Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof |
| AU2013274093A1 (en) * | 2012-06-14 | 2014-12-18 | Bioventures, Llc | Compositions and methods for non-invasive detection and treatment of hypoxic cells in vivo |
| US8821838B2 (en) | 2012-08-23 | 2014-09-02 | General Electric Company | Nanoparticulate compositions for diagnostic imaging |
| BR112015017490A2 (pt) * | 2013-01-25 | 2017-07-11 | Nanobiotix | uso de nanopartículas inorgânicas |
| EP2958553B1 (en) * | 2013-02-19 | 2018-02-14 | National Health Research Institutes | Caged platinum nanoclusters for anticancer chemotherapeutics |
| JP6387400B2 (ja) | 2013-05-30 | 2018-09-05 | ナノビオティックスＮａｎｏｂｉｏｔｉｘ | 医薬組成物、その製造および使用 |
| MX2015017774A (es) * | 2013-06-20 | 2016-03-31 | Nanobiotix | Composiciones y metodos para el uso en el diagnostico medico. |
| EP2886128A1 (en) | 2013-12-20 | 2015-06-24 | Nanobiotix | Pharmaceutical composition comprising nanoparticles, preparation and uses thereof |
| DK3229776T3 (da) | 2014-11-25 | 2023-07-31 | Curadigm Sas | Farmaceutisk sammensætning, der kombinerer mindst to særskilte nanopartikler og en farmaceutisk forbindelse, fremstilling og anvendelser deraf |
| UA123665C2 (uk) | 2014-11-25 | 2021-05-12 | Кюрадігм Сас | Фармацевтична композиція, її одержання і застосування |
| DK3223796T3 (da) | 2014-11-25 | 2021-09-27 | Curadigm Sas | Farmaceutiske sammensætninger, fremstilling og anvendelser deraf |
| AU2015352688A1 (en) | 2014-11-25 | 2017-07-13 | Nanobiotix | Pharmaceutical composition, preparation and uses thereof |
| PT3229843T (pt) | 2014-11-25 | 2020-03-06 | Curadigm Sas | Composição farmacêutica, a sua preparação e as suas utilizações |
| WO2016112314A1 (en) * | 2015-01-08 | 2016-07-14 | Purdue Research Foundation | Non-toxic formulations of radio-luminescent nanoparticles for use as cancer radio-sensitizing agents |
| TW201705977A (zh) * | 2015-05-28 | 2017-02-16 | 奈諾生技公司 | 作為治療疫苗之奈米顆粒 |
| US11389536B2 (en) | 2015-07-17 | 2022-07-19 | BioCurity Pharmaceuticals Inc. | Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent |
| CN109010828B (zh) * | 2018-10-12 | 2020-10-20 | 中国科学院高能物理研究所 | 一种二硫化钼/二氧化铪的复合纳米材料、其制备方法及用途 |
| CN109616308B (zh) * | 2018-11-07 | 2020-09-04 | 湖北第二师范学院 | 一种球形纳米氧化铱dna提取磁性粉末及其生产方法 |
| CN109771645B (zh) * | 2019-03-07 | 2021-08-24 | 广西师范大学 | 一种二氧化钌复合卵清蛋白纳米材料的制备及其应用 |
| US20230211175A1 (en) * | 2020-05-26 | 2023-07-06 | Nanobiotix S.A. | Nanoparticles, ionizing radiation and innovative therapeutic combinations thereof |
| JP2023549698A (ja) * | 2020-11-05 | 2023-11-29 | ナノビオティックス | がんの治療のためのナノ粒子の組成物 |
| EP4255488A1 (en) * | 2020-12-01 | 2023-10-11 | Nanobiotix | Porous, high-z and carbon-free particles as radioenhancers |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6287526A (ja) * | 1985-10-11 | 1987-04-22 | Akira Fujishima | 抗腫瘍剤 |
| US6645464B1 (en) | 1998-07-30 | 2003-11-11 | James F. Hainfeld | Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy |
| EP1696957A2 (en) | 2003-12-17 | 2006-09-06 | Philips Intellectual Property & Standards GmbH | Radiation therapy and medical imaging using uv emitting nanoparticles |
| FR2869803B1 (fr) * | 2004-05-10 | 2006-07-28 | Nanobiotix Sarl | Particules activables, preparation et utilisations |
| US20070092927A1 (en) * | 2005-06-13 | 2007-04-26 | University Of Dayton | Photocatalytic particles with directed and controlled redox activity |
| JP2007075696A (ja) * | 2005-09-13 | 2007-03-29 | Mitsubishi Materials Corp | 多孔質光触媒膜 |
| WO2008007290A2 (en) * | 2006-07-10 | 2008-01-17 | Philips Intellectual Property & Standards Gmbh | Core-shell nanoparticles for thearapy and imaging purposes |
| EP1920784A1 (en) * | 2006-11-13 | 2008-05-14 | Koninklijke Philips Electronics N.V. | Radiation sensitizers in ionizing radiation therapy and imaging |
-
2008
- 2008-06-05 EP EP08157686A patent/EP2130553A1/en not_active Withdrawn
-
2009
- 2009-06-04 MX MX2010013322A patent/MX2010013322A/es active IP Right Grant
- 2009-06-04 ES ES09757595.5T patent/ES2602048T3/es active Active
- 2009-06-04 BR BRPI0913410-7A patent/BRPI0913410B1/pt active IP Right Grant
- 2009-06-04 LT LTEP09757595.5T patent/LT2300054T/lt unknown
- 2009-06-04 LT LTEP16187263.5T patent/LT3150227T/lt unknown
- 2009-06-04 HU HUE09757595A patent/HUE030669T2/en unknown
- 2009-06-04 KR KR1020117000259A patent/KR101639281B1/ko active IP Right Grant
- 2009-06-04 AU AU2009254550A patent/AU2009254550B2/en active Active
- 2009-06-04 HU HUE16187263A patent/HUE040247T2/hu unknown
- 2009-06-04 SI SI200931905T patent/SI3150227T1/sl unknown
- 2009-06-04 DK DK09757595.5T patent/DK2300054T3/en active
- 2009-06-04 PL PL09757595T patent/PL2300054T3/pl unknown
- 2009-06-04 SG SG10201405288WA patent/SG10201405288WA/en unknown
- 2009-06-04 EA EA201071429A patent/EA023012B1/ru unknown
- 2009-06-04 WO PCT/EP2009/056880 patent/WO2009147214A2/en active Application Filing
- 2009-06-04 PT PT16187263T patent/PT3150227T/pt unknown
- 2009-06-04 PL PL16187263T patent/PL3150227T3/pl unknown
- 2009-06-04 EP EP09757595.5A patent/EP2300054B1/en active Active
- 2009-06-04 EP EP18203014.8A patent/EP3461502A1/en active Pending
- 2009-06-04 NZ NZ589888A patent/NZ589888A/en unknown
- 2009-06-04 US US12/994,162 patent/US8845507B2/en active Active
- 2009-06-04 SI SI200931555A patent/SI2300054T1/sl unknown
- 2009-06-04 CA CA2727576A patent/CA2727576C/en active Active
- 2009-06-04 CN CN2009801211030A patent/CN102056628B/zh active Active
- 2009-06-04 JP JP2011512129A patent/JP5734181B2/ja active Active
- 2009-06-04 TR TR2018/19077T patent/TR201819077T4/tr unknown
- 2009-06-04 DK DK16187263.5T patent/DK3150227T3/en active
- 2009-06-04 EP EP16187263.5A patent/EP3150227B1/en active Active
- 2009-06-04 ES ES16187263T patent/ES2702249T3/es active Active
- 2009-06-04 PT PT97575955T patent/PT2300054T/pt unknown
-
2010
- 2010-11-29 IL IL209625A patent/IL209625A/en active IP Right Grant
-
2011
- 2011-01-04 ZA ZA2011/00082A patent/ZA201100082B/en unknown
- 2011-01-04 MA MA33490A patent/MA32453B1/fr unknown
-
2016
- 2016-11-01 CY CY20161101109T patent/CY1118217T1/el unknown
- 2016-11-07 HR HRP20161465TT patent/HRP20161465T8/hr unknown
-
2018
- 2018-11-27 HR HRP20181993TT patent/HRP20181993T1/hr unknown
- 2018-12-19 CY CY181101377T patent/CY1121078T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121078T1 (el) | Ανοργανα νανοσωματιδια υψηλης πυκνοτητας για καταστροφη κυτταρων in-vivo | |
| Esplen et al. | Physics and biology of ultrahigh dose-rate (FLASH) radiotherapy: a topical review | |
| Andreo | On the clinical spatial resolution achievable with protons and heavier charged particle radiotherapy beams | |
| Lechtman et al. | Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location | |
| CY1118600T1 (el) | Μεταλλικα νανοσωματιδια, παρασκευη και χρησεις αυτων | |
| CY1121838T1 (el) | Συνθεσεις που περιλαμβανουν νανοσωματιδια οξειδιου του αφνιου (iv) ή οξειδιου του ρηνιου (iv) σε συνδυασμο με ιονιζουσες ακτινοβολιες για αντιμετωπιση καρκινου | |
| Nakamura et al. | Antitumor effect of boron nitride nanotubes in combination with thermal neutron irradiation on BNCT | |
| DE602005008731D1 (de) | Durch röntgen- und/oder uv-strahlen aktivierbare partikel, deren herstellung und deren therapeutische oder diagnostische verwendung | |
| Oppelt et al. | Comparison study of in vivo dose response to laser-driven versus conventional electron beam | |
| Amato et al. | Gold nanoparticles as a sensitising agent in external beam radiotherapy and brachytherapy: a feasibility study through Monte Carlo simulation | |
| WO2010132569A3 (en) | Radiation dosimeters for quantifying the dose of radiation applied during radiation therapy | |
| Chow et al. | Flash radiotherapy: Innovative cancer treatment | |
| Algethami et al. | Radiation dose enhancement using Bi2S3 nanoparticles in cultured mouse PC3 prostate and B16 melanoma cells | |
| Kwon et al. | Spatial distributions of dose enhancement around a gold nanoparticle at several depths of proton Bragg peak | |
| Cai et al. | Enhanced DNA damage induced by secondary electron emission from a tantalum surface exposed to soft X rays | |
| Beyzadeoglu et al. | Evaluation of scatter dose of dental titanium implants exposed to photon beams of different energies and irradiation angles in head and neck radiotherapy | |
| Hirsch et al. | Polymethylmethacrylate and radioisotopes in vertebral augmentation: an explanation of underlying principles | |
| WO2014033112A3 (de) | Dosismessvorrichtung | |
| HRP20190848T1 (hr) | Pripravci namijenjeni upotrebi u onkologiji | |
| Khosravi et al. | Target dose enhancement factor alterations related to interaction between the photon beam energy and gold nanoparticles' size in external radiotherapy: using Monte Carlo method. | |
| HRP20191272T1 (hr) | Pripravci koji sadrže nano čestice hafnium (iv) oksida ili renij (iv) oksida u kombinaciji s ionizirajućim zračenjem za liječenje raka | |
| Safronov et al. | Magnetite nanoparticles for nonradionuclide brachytherapy | |
| Jasim et al. | The Effect of Doubled Concentration of Nanoparticles with Gamma-Rays Energy as Simulation Radiotherapy in Lung Cancer. | |
| Ishak-Boushakia et al. | Energy Responses of Radiophotoluminescent Glass Dosimeters to Photons and Electrons Used in Radiotherapy Treatments | |
| Medina C et al. | Neutron spectrum for neutron capture therapy in boron |